Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation

Advanced human thyroid cancers, particularly those that are refractory to treatment with radioiodine (RAI), have a high prevalence of BRAF (v-raf murine sarcoma viral oncogene homolog B1) mutations. However, the degree to which these cancers are dependent on BRAF expression is still unclear. To addr...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chakravarty, Debyani, Santos, Elmer, Ryder, Mabel, Knauf, Jeffrey A., Liao, Xiao-Hui, West, Brian L., Bollag, Gideon, Kolesnick, Richard, Thin, Tin Htwe, Rosen, Neal, Zanzonico, Pat, Larson, Steven M., Refetoff, Samuel, Ghossein, Ronald, Fagin, James A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Clinical Investigation 2011
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225989/
https://ncbi.nlm.nih.gov/pubmed/22105174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI46382
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg